Celltrion
068270.KS
#678
Rank
NZ$62.55 B
Marketcap
NZ$285.92
Share price
-1.61%
Change (1 day)
37.21%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): NZ$3.22

According to Celltrion 's latest financial reports the company's current EPS (TTM) is NZ$3.17. In 2024 the company made an earnings per share (EPS) of NZ$2.25 a decrease over its 2023 EPS that were of NZ$4.46.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$3.2243.36%
2024NZ$2.25-49.57%
2023NZ$4.46-2.08%
2022NZ$4.55-11.72%
2021NZ$5.162.03%
2020NZ$5.0682.8%
2019NZ$2.7718.31%
2018NZ$2.34-36.33%
2017NZ$3.67161.25%
2016NZ$1.412.86%
2015NZ$1.3717.84%
2014NZ$1.165.87%
2013NZ$1.10-70.85%
2012NZ$3.76134.09%
2011NZ$1.6043.59%
2010NZ$1.1274.49%
2009NZ$0.64317.8%
2008NZ$0.15-71.7%
2007NZ$0.54